"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Pharmaceutical ...

ATLANTA — Artificial intelligence is revolutionizing drug development, significantly reducing the time it takes to bring life-saving treatments to market, drug companies say. Traditionally, developing ...

A portable device that can instantly detect dangerous street drugs at extremely low concentrations has been developed at the University of Bath in the UK. The device, which is being trialled by ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...

Scientists have developed a revolutionary AI "fingerprint" technology that can accurately show how cancer cells respond to new drugs, by simply observing changes to their shape. The new technology, ...

A team has developed a large-scale drug screening technique that can track target molecule behavior within cells. The researchers verified their technique by testing the epidermal growth factor ...

New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's cells that help drive disease, as these are potential targets for new ...

The pharmaceutical industry is entering an inflection point driven by the recognition that highly potent cancer drugs are only as effective as their ability to reach tumors with sufficient ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The pharmaceutical industry faces the challenge of balancing innovation with affordability.